KẸDI Aworan:
Orukọ akede
Forbes
InnovationRx: FDA OKs Oògùn Pipadanu iwuwo Lilly
Apejuwe ọna asopọ
InnovationRx jẹ iṣiro ọsẹ rẹ ti awọn iroyin ilera. Lati gba ninu apo-iwọle rẹ, ṣe alabapin si ibi.
Lori ipele ti kemikali, Zepbound jẹ kanna bi Mounjaro, Lilly's GLP-1 agonist ti fọwọsi tẹlẹ lati tọju àtọgbẹ. Aṣẹ-lori-ara 2017 The Associated Press. Gbogbo awọn ẹtọ wa ni ipamọ.
FDA fọwọsi Eli Lilly's…
Lori ipele ti kemikali, Zepbound jẹ kanna bi Mounjaro, Lilly's GLP-1 agonist ti fọwọsi tẹlẹ lati tọju àtọgbẹ. Aṣẹ-lori-ara 2017 The Associated Press. Gbogbo awọn ẹtọ wa ni ipamọ.
FDA fọwọsi Eli Lilly's…
- Ikede: Orukọ akedeForbes
- Olutọju ọna asopọ: superadmin
- November 10, 2023
Awọn asọtẹlẹ 263 
